Skip to main content
Erschienen in:

10.11.2019 | Case Report

A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl

verfasst von: Shi-Jun Li, Jie Xiong, Yu He, Yang-Yang Xiao, Ding-An Mao, Li-Qun Liu

Erschienen in: Child's Nervous System | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Moyamoya disease is a chronic cerebral vascular disease characterized by progressive occlusion of the cerebral arteries and resulting in the development of abnormal collateral circulation. We report a case of moyamoya disease in a 3-year-old Chinese girl with partly reversible white matter lesions. This case indicates that, in pediatric moyamoya disease, white matter lesions may be associated with cerebral ischemia, and they may be reversible after treatment.
Literatur
1.
Zurück zum Zitat Takeuchi K, Shimizu K (1957) Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9:37–43 Takeuchi K, Shimizu K (1957) Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9:37–43
2.
Zurück zum Zitat Piao J, Wu W, Yang Z (2015) Research progress of moyamoya disease in children. Int J Med Sci 12:566–575CrossRef Piao J, Wu W, Yang Z (2015) Research progress of moyamoya disease in children. Int J Med Sci 12:566–575CrossRef
3.
Zurück zum Zitat Fujimura M, Tominaga T (2015) Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo) 55:189–193CrossRef Fujimura M, Tominaga T (2015) Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo) 55:189–193CrossRef
4.
Zurück zum Zitat Liao X, Deng J, Dai W, Zhang T, Yan J (2017) Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Environ Health Prev Med 22:75CrossRef Liao X, Deng J, Dai W, Zhang T, Yan J (2017) Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Environ Health Prev Med 22:75CrossRef
5.
Zurück zum Zitat Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, Okuda H, Mineharu Y, Takagi Y, Youssefian S, Iida H, Miyamoto S, Ihara M, Kobayashi H, Koizumi A (2018) Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep 8:3607CrossRef Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, Okuda H, Mineharu Y, Takagi Y, Youssefian S, Iida H, Miyamoto S, Ihara M, Kobayashi H, Koizumi A (2018) Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep 8:3607CrossRef
6.
Zurück zum Zitat Kim WH, Kim SD, Nam MH, Jung JM, Jin SW, Ha SK, Lim DJ, Lee HB (2019) Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism. Childs Nerv Syst 35:309–314CrossRef Kim WH, Kim SD, Nam MH, Jung JM, Jin SW, Ha SK, Lim DJ, Lee HB (2019) Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism. Childs Nerv Syst 35:309–314CrossRef
7.
Zurück zum Zitat Matsuda Y, Mineharu Y, Kimura M, Takagi Y, Kobayashi H, Hitomi T, Harada KH, Uchihashi Y, Funaki T, Miyamoto S, Koizumi A (2017) RNF213 p.R4810K variant and intracranial arterial stenosis or occlusion in relatives of patients with moyamoya disease. J Stroke Cerebrovasc Dis 26:1841–1847CrossRef Matsuda Y, Mineharu Y, Kimura M, Takagi Y, Kobayashi H, Hitomi T, Harada KH, Uchihashi Y, Funaki T, Miyamoto S, Koizumi A (2017) RNF213 p.R4810K variant and intracranial arterial stenosis or occlusion in relatives of patients with moyamoya disease. J Stroke Cerebrovasc Dis 26:1841–1847CrossRef
8.
Zurück zum Zitat Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, Yu L, Lu C, Liu F, Zhou J, Zhang X, Zhao J (2017) RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg 126:1106–1113CrossRef Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, Yu L, Lu C, Liu F, Zhou J, Zhang X, Zhao J (2017) RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg 126:1106–1113CrossRef
9.
Zurück zum Zitat Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW (2016) Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg 124:1221–1227CrossRef Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW (2016) Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg 124:1221–1227CrossRef
10.
Zurück zum Zitat Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identifcation of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6:e22542CrossRef Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identifcation of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6:e22542CrossRef
11.
Zurück zum Zitat Ernst M, Boers AMM, Forkert ND, Berkhemer OA, Roos YB, Dippel DWJ, Van der Lugt A, Van Oostenbrugge RJ, Van Zwam WH, Vettorazzi E, Fiehler J, Marquering HA, Majoie CBLM, Gellissen S (2018) Impact of ischemic lesion location on the mRS score in patients with ischemic stroke: a voxel-based approach. AJNR Am J Neuroradiol 39:1989–1994CrossRef Ernst M, Boers AMM, Forkert ND, Berkhemer OA, Roos YB, Dippel DWJ, Van der Lugt A, Van Oostenbrugge RJ, Van Zwam WH, Vettorazzi E, Fiehler J, Marquering HA, Majoie CBLM, Gellissen S (2018) Impact of ischemic lesion location on the mRS score in patients with ischemic stroke: a voxel-based approach. AJNR Am J Neuroradiol 39:1989–1994CrossRef
12.
Zurück zum Zitat Von Rennenberg R, Siegerink B, Ganeshan R, Villringer K, Doehner W, Audebert HJ, Endres M, Nolte CH, Scheitz JF (2019) High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke. J Neurol 266:37–45CrossRef Von Rennenberg R, Siegerink B, Ganeshan R, Villringer K, Doehner W, Audebert HJ, Endres M, Nolte CH, Scheitz JF (2019) High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke. J Neurol 266:37–45CrossRef
13.
Zurück zum Zitat Haussen DC, Lima A, Frankel M, Anderson A, Belagaje S, Nahab F, Rangaraju S, Nogueira RG (2015) Sulcal effacement with preserved gray-white junction: a sign of reversible ischemia. Stroke 46:1704–1706CrossRef Haussen DC, Lima A, Frankel M, Anderson A, Belagaje S, Nahab F, Rangaraju S, Nogueira RG (2015) Sulcal effacement with preserved gray-white junction: a sign of reversible ischemia. Stroke 46:1704–1706CrossRef
14.
Zurück zum Zitat Holmegaard L, Jensen C, Redfors P, Blomstrand C, Jern C, Jood K (2018) Long-term progression of white matter hyperintensities in ischemic stroke. Acta Neurol Scand 138:548–556CrossRef Holmegaard L, Jensen C, Redfors P, Blomstrand C, Jern C, Jood K (2018) Long-term progression of white matter hyperintensities in ischemic stroke. Acta Neurol Scand 138:548–556CrossRef
15.
Zurück zum Zitat Tamura G, Ihara S, Morota N (2016) Reversible diffusion weighted imaging hyperintensities during the acute phase of ischemic stroke in pediatric moyamoya disease: a case report. Childs Nerv Syst 32:1531–1535CrossRef Tamura G, Ihara S, Morota N (2016) Reversible diffusion weighted imaging hyperintensities during the acute phase of ischemic stroke in pediatric moyamoya disease: a case report. Childs Nerv Syst 32:1531–1535CrossRef
17.
Zurück zum Zitat Kim TK, Eun BL, Cha SH, Chung KB, Kim JH, Kim BH, Chung HH (2003) Moyamoya disease in a child with previous acute necrotizing encephalopathy. Pediatr Radiol 33:644–647CrossRef Kim TK, Eun BL, Cha SH, Chung KB, Kim JH, Kim BH, Chung HH (2003) Moyamoya disease in a child with previous acute necrotizing encephalopathy. Pediatr Radiol 33:644–647CrossRef
18.
Zurück zum Zitat Sasannejad P, Rezaei F, Bidaki R, Zarepur E (2018) Rare presentation of moyamoya disease with subacute presentation in Iran. Iran J Child Neurol 12:89–93PubMedPubMedCentral Sasannejad P, Rezaei F, Bidaki R, Zarepur E (2018) Rare presentation of moyamoya disease with subacute presentation in Iran. Iran J Child Neurol 12:89–93PubMedPubMedCentral
19.
Zurück zum Zitat Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J (2012) Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis 21:873–882CrossRef Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J (2012) Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis 21:873–882CrossRef
20.
Zurück zum Zitat Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, Tominaga T (2018) Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult moyamoya disease. J Stroke Cerebrovasc Dis 27:e172–e176CrossRef Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, Tominaga T (2018) Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult moyamoya disease. J Stroke Cerebrovasc Dis 27:e172–e176CrossRef
21.
Zurück zum Zitat Komori A, Mizu D, Ariyoshi K (2018) Posterior reversible encephalopathy syndrome: a rare childhood case with unconsciousness. J Emerg Med 54:540–543CrossRef Komori A, Mizu D, Ariyoshi K (2018) Posterior reversible encephalopathy syndrome: a rare childhood case with unconsciousness. J Emerg Med 54:540–543CrossRef
22.
Zurück zum Zitat Chen HA, Lin YJ, Chen PC, Chen TY, Lin KC, Cheng HH (2010) Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy. Int J Rheum Dis 13:e79–e82CrossRef Chen HA, Lin YJ, Chen PC, Chen TY, Lin KC, Cheng HH (2010) Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy. Int J Rheum Dis 13:e79–e82CrossRef
23.
Zurück zum Zitat Guggenberger K, Urbach H (2018) MRI alterations in immunomodulation. Nervenarzt 89:945–957CrossRef Guggenberger K, Urbach H (2018) MRI alterations in immunomodulation. Nervenarzt 89:945–957CrossRef
24.
Zurück zum Zitat Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, Takahashi JC (2017) Clinical implication of the cortical hyper intensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease. J MNeurosurg 126:1–7CrossRef Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, Takahashi JC (2017) Clinical implication of the cortical hyper intensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease. J MNeurosurg 126:1–7CrossRef
25.
Zurück zum Zitat Takanashi J (2011) Moyamoya disease in children. Brain and Development 33:229–234CrossRef Takanashi J (2011) Moyamoya disease in children. Brain and Development 33:229–234CrossRef
26.
Zurück zum Zitat Bedini G, Blecharz KG, Nava S, Vajkoczy P, Alessandri G, Ranieri M, Acerbi F, Ferroli P, Riva D, Esposito S, Pantaleoni C, Nardocci N, Zibordi F, Ciceri E, Parati EA, Bersano A (2016) Vasculogenic and angiogenic pathways in moyamoya disease. Curr Med Chem 23:315–345CrossRef Bedini G, Blecharz KG, Nava S, Vajkoczy P, Alessandri G, Ranieri M, Acerbi F, Ferroli P, Riva D, Esposito S, Pantaleoni C, Nardocci N, Zibordi F, Ciceri E, Parati EA, Bersano A (2016) Vasculogenic and angiogenic pathways in moyamoya disease. Curr Med Chem 23:315–345CrossRef
27.
Zurück zum Zitat Research committee on the pathology and treatment of spontaneous occlusion of the circle of Willis (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neuro Med Chir (Tokyo) 52:245–266CrossRef Research committee on the pathology and treatment of spontaneous occlusion of the circle of Willis (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neuro Med Chir (Tokyo) 52:245–266CrossRef
28.
Zurück zum Zitat Smith ER, Scott M (2012) Spontaneous occlusion of the circle of Willis in children:pediatric moyamoya summary with proposed evidence-based practice guidelines. J Neurosurg Pediatrics 9:353–360CrossRef Smith ER, Scott M (2012) Spontaneous occlusion of the circle of Willis in children:pediatric moyamoya summary with proposed evidence-based practice guidelines. J Neurosurg Pediatrics 9:353–360CrossRef
Metadaten
Titel
A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl
verfasst von
Shi-Jun Li
Jie Xiong
Yu He
Yang-Yang Xiao
Ding-An Mao
Li-Qun Liu
Publikationsdatum
10.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 1/2020
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04391-x

Neu im Fachgebiet Chirurgie

Krebs-Op. besser erst nach mehrwöchigem Rauchverzicht?

Aktive Raucher haben nach onkologischen Operationen ein höheres Komplikationsrisiko als Nieraucher, aber auch als Exraucher. Damit der Rauchstopp einen Nutzen hat, darf er aber nicht zu kurz vor der Op. erfolgen, wie eine Metaanalyse nahelegt.

Periprozeduraler Myokardschaden nach NSTEMI prognostisch bedeutsam

Erleiden NSTEMI-Patienten und -Patientinnen infolge einer PCI Myokardschädigungen mit oder ohne Infarkt, erhöht das die Gesamtmortalität und das Risiko für weitere schwere Herzereignisse. Dafür sprechen zumindest Daten aus zwei italienischen Zentren.

Höhere Sterberate nach Freitags-Op.

Wer direkt vor dem Wochenende operiert wird, läuft eher Gefahr, in den folgenden Wochen und Monaten zu sterben, als Menschen mit einer Op. unmittelbar nach dem Wochenende. Der Unterschied bei der Sterberate beläuft sich nach Daten einer US-Analyse auf etwa 10%.

Ärztinnen überholen Ärzte bei Praxisgründungen

Bei Praxisgründungen haben inzwischen die Frauen deutlich die Nase vorn: Seit zehn Jahren wagen laut apoBank mehr Ärztinnen als Ärzte den Schritt in die Selbstständigkeit. In puncto Finanzierung sind sie aber vorsichtiger als die männlichen Kollegen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.